The Indian Pharmaceutical Association (IPA) in collaboration with European Directorate of Quality of Medicines (EDQM) is conducting a two day symposium on the changing regulatory scenario and opportunities of Indian companies in European market at Hotel Intercontinental The Grand Hotel, Mumbai on 28th and 29th November 2007.

The IPA EDQM IDMA Symposium 2007 with a theme - Gateway to EU markets: EDQM - aims to provide a common platform to the visiting officials from EDQM and the Indian regulators and industry to deliberate on some of the major issues in the regulatory submissions, approvals and inspection procedures with the European regulatory authority, according to IPA officials.

"The symposium will be addressed by officials from EDQM, senior members with the Indian Pharmacopoeia Commission and the top brass from the regulatory, QA and R&D sectors of the Indian Pharmaceutical industry," said S D Joag, general secretary, IPA.

The experts will discuss on topics including the recent developments at EDQM, IPC developments, COS/CEP current regulatory process - regulatory submission, approval and revision process, The European Pharmacopoeia 6th edition etc.